LianBio American Depositary Shares
LIANUnlisted companyLianBio American Depositary Shares in brief
LianBio American Depositary Shares is an unlisted company in the Healthcare sector, based in New Jersey, USA. In the year to Dec 2021 it had sales of $0 M and a net loss of $196 M. It employs about 107 people.
Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.
About LianBio American Depositary Shares
LianBio is a biopharmaceutical company that treat the specific cause of diseases like cardiovascular, oncology and respiratory. The company total assets are 279.2 million USD as on 2020. The headquarters is in USA.
LianBio American Depositary Shares timeline
- 2021
- 🔔· approximateInitial public offering on Nasdaq
Events of LianBio American Depositary Shares from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about LianBio American Depositary Shares
- Acquisitions and changes
- No longer listed: ticker LIAN is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in USA: #3,220 (Jan 2022) · #3,798 (Dec 2022) · #3,541 (Jul 2023) · #2,628 (Jan 2024)
Key ratios
- P/E ratio
- n/m (loss)
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- —
- Operating margin
- —
- Return on equity
- -50.6%
- Liabilities / assets
- 9.2%
- Revenue per employee
- $0 K
- Profit per employee
- $-1.8 M
Annual results
- Revenue
- $0 M
- Operating income
- —
- Net income
- $-196 M
Dec-2021 ending year
Balance sheet
- Total assets
- $426 M
- Total liabilities
- $39 M
- Total equity
- $387 M
Dec-2021 ending year
How LianBio American Depositary Shares compares in Healthcare
- Revenue$0 M · higher than 0% of 1,807
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| LianBio American Depositary Shares🇺🇸 | $451 M | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- UnitedHealth Group Incorporated$367.7 B
- Merck & Co., Inc.$359.8 B
How current the figures are
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- Dec-2021 ending year
- Balance sheet:
- Dec-2021 ending year
- Employees:
- As on 2021
- Profile updated:
- Nov 14, 2026
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at LianBio American Depositary Shares? Verify and update this profile — free
Show LianBio American Depositary Shares's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.